- Quarterly
- Annual
- TTM
-
Export .csv
-
Download Image
-
Copy link
-
Embed code
Share URL
Bar Chart preview
NovoCure Limited Operating Income Margin is -26.84% for the Trailing 12 Months (TTM) ending March 31, 2025, a -34.11% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits. NovoCure Limited Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -40.74%, a 42.88% change year over year. NovoCure Limited Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -28.51%, a 240.41% change year over year. NovoCure Limited Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -8.38%, a -231.06% change year over year. NovoCure Limited Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 6.39%, a 1,232.29% change year over year.
StockViz
Embed chart view
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max